Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients

We report the case of 2 patients with relapsed/refractory peripheral T-cell lymphoma treated with valemetostat tosilate, a selective dual inhibitor of histone-lysine N-methyltransferases enhancer of zeste homolog 1 and 2, and subsequently bridged to allogeneic stem cell transplantation. Valemetosta...

Full description

Saved in:
Bibliographic Details
Main Authors: Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani
Format: Article
Language:English
Published: PAGEPress Publications 2024-01-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:https://mjhid.org/mjhid/article/view/5485
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841564507924594688
author Gianmarco Bagnato
Vittorio Stefoni
Alessandro Broccoli
Lisa Argnani
Cinzia Pellegrini
Beatrice Casadei
Francesca Bonifazi
Pier Luigi Zinzani
author_facet Gianmarco Bagnato
Vittorio Stefoni
Alessandro Broccoli
Lisa Argnani
Cinzia Pellegrini
Beatrice Casadei
Francesca Bonifazi
Pier Luigi Zinzani
author_sort Gianmarco Bagnato
collection DOAJ
description We report the case of 2 patients with relapsed/refractory peripheral T-cell lymphoma treated with valemetostat tosilate, a selective dual inhibitor of histone-lysine N-methyltransferases enhancer of zeste homolog 1 and 2, and subsequently bridged to allogeneic stem cell transplantation. Valemetostat led to a quick response and was well tolerated, offering as a promising bridge therapy to transplantation for patients with relapsed/refractory peripheral T-cell lymphoma which is still an unmet medical need.
format Article
id doaj-art-f3bcfe6454db4c48926e6d674464f884
institution Kabale University
issn 2035-3006
language English
publishDate 2024-01-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-f3bcfe6454db4c48926e6d674464f8842025-01-02T22:43:29ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062024-01-0116110.4084/MJHID.2024.004Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patientsGianmarco BagnatoVittorio StefoniAlessandro BroccoliLisa ArgnaniCinzia PellegriniBeatrice CasadeiFrancesca BonifaziPier Luigi Zinzani0a:1:{s:5:"en_US";s:71:"Institute of Hematology “L. e A. Seràgnoli”, University of Bologna";} We report the case of 2 patients with relapsed/refractory peripheral T-cell lymphoma treated with valemetostat tosilate, a selective dual inhibitor of histone-lysine N-methyltransferases enhancer of zeste homolog 1 and 2, and subsequently bridged to allogeneic stem cell transplantation. Valemetostat led to a quick response and was well tolerated, offering as a promising bridge therapy to transplantation for patients with relapsed/refractory peripheral T-cell lymphoma which is still an unmet medical need. https://mjhid.org/mjhid/article/view/5485ValemetostatPeripheral T-cell LymphomaAllogeneic TransplantationRefractory Disease
spellingShingle Gianmarco Bagnato
Vittorio Stefoni
Alessandro Broccoli
Lisa Argnani
Cinzia Pellegrini
Beatrice Casadei
Francesca Bonifazi
Pier Luigi Zinzani
Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients
Mediterranean Journal of Hematology and Infectious Diseases
Valemetostat
Peripheral T-cell Lymphoma
Allogeneic Transplantation
Refractory Disease
title Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients
title_full Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients
title_fullStr Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients
title_full_unstemmed Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients
title_short Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients
title_sort successful bridging to allogeneic transplantation with valemetostat in two refractory relapsed peripheral t cell lymphoma patients
topic Valemetostat
Peripheral T-cell Lymphoma
Allogeneic Transplantation
Refractory Disease
url https://mjhid.org/mjhid/article/view/5485
work_keys_str_mv AT gianmarcobagnato successfulbridgingtoallogeneictransplantationwithvalemetostatintworefractoryrelapsedperipheraltcelllymphomapatients
AT vittoriostefoni successfulbridgingtoallogeneictransplantationwithvalemetostatintworefractoryrelapsedperipheraltcelllymphomapatients
AT alessandrobroccoli successfulbridgingtoallogeneictransplantationwithvalemetostatintworefractoryrelapsedperipheraltcelllymphomapatients
AT lisaargnani successfulbridgingtoallogeneictransplantationwithvalemetostatintworefractoryrelapsedperipheraltcelllymphomapatients
AT cinziapellegrini successfulbridgingtoallogeneictransplantationwithvalemetostatintworefractoryrelapsedperipheraltcelllymphomapatients
AT beatricecasadei successfulbridgingtoallogeneictransplantationwithvalemetostatintworefractoryrelapsedperipheraltcelllymphomapatients
AT francescabonifazi successfulbridgingtoallogeneictransplantationwithvalemetostatintworefractoryrelapsedperipheraltcelllymphomapatients
AT pierluigizinzani successfulbridgingtoallogeneictransplantationwithvalemetostatintworefractoryrelapsedperipheraltcelllymphomapatients